Status:
COMPLETED
Ovarian Reserve After Ovarian Hemostasis by Floseal Matrix
Lead Sponsor:
CHA University
Conditions:
Ovarian Cysts
Eligibility:
FEMALE
18-45 years
Phase:
PHASE3
Brief Summary
Laparoscopy has become the gold standard for the surgical treatment of benign ovarian cysts and is usually performed by stripping the ovarian cyst wall, followed by bleeding control of the ovarian wou...
Eligibility Criteria
Inclusion
- age between 18 and 45 years
- maximum diameter of the cyst between 3 and 10 cm
- regular menstrual bleeding (defined as cycle length less than 21 or more than 45 days)
- appropriate medical status for laparoscopic surgery (American Society of Anesthesiologists Physical Status classification 1 or 2).
Exclusion
- any suspicious finding of malignant ovarian diseases
- postmenopausal status
- baseline serum AMH \< 0.50 ng/mL
- pregnancy
- lactation
- any other endocrine diseases (such as thyroid dysfunction, hyperprolactinemia, or Cushing's syndrome)
- use of hormonal treatments in the 3 months before enrollment
Key Trial Info
Start Date :
December 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01857466
Start Date
December 1 2012
End Date
October 1 2013
Last Update
June 25 2014
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
National Health Insurance Service Ilsan Hospital
Goyang, South Korea
2
CHA Gangnam Medical Center
Seoul, South Korea
3
Kangbuk Samsung Hospital, Sungkyunkwan University
Seoul, South Korea